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Embryonic stem cell (ESC) pluripotency requires
bivalent epigenetic modifications of key develop-
mental genes regulated by various transcription
factors and chromatin-modifying enzymes. How
these factors coordinate with one another to main-
tain the bivalent chromatin state so that ESCs can
undergo rapid self-renewal while retaining pluripo-
tency is poorly understood. We report that Utf1, a
target of Oct4 and Sox2, is a bivalent chromatin
component that buffers poised states of bivalent
genes. By limiting PRC2 loading and histone 3
lysine-27 trimethylation, Utf1 sets proper activation
thresholds for bivalent genes. It also promotes
nuclear tagging of messenger RNAs (mRNAs) tran-
scribed from insufficiently silenced bivalent genes
for cytoplasmic degradation through mRNA decapp-
ing. These opposing functions of Utf1 promote coor-
dinated differentiation. The mRNA degradation func-
tion also ensures rapid cell proliferation by blocking
the Myc-Arf feedback control. Thus, Utf1 couples
the core pluripotency factors with Myc and PRC2
networks to promote the pluripotency and prolifera-
tion of ESCs.
INTRODUCTION
Embryonic stem cells (ESCs) undergo rapid self-renewal and can
differentiate into any cell type. These features depend on tran-
scription factors including Oct4, Sox2, and Nanog (Boyer et al.,
2005; Chen et al., 2008; Kim et al., 2008; Loh et al., 2006) that
form the core pluripotency network (Orkin and Hochedlinger,576 Cell 151, 576–589, October 26, 2012 ª2012 Elsevier Inc.2011). This ESC-specific network interacts with both the
Myc-based transcription network and a network of chromatin-
modifying complexes including the polycomb-repressive
complex 2 (PRC2). Together these three networks occupy and
regulate a large number of target genes essential for the self-
renewal and differentiation of ESCs (Boyer et al., 2006; Hu
et al., 2009; Kim et al., 2010; Ku et al., 2008; Lee et al., 2006).
Although a few factors have been shown to coordinate some
aspects of these networks in ESCs (Orkin and Hochedlinger,
2011), how all three networks are functionally integrated is
unknown.
The Myc-centered network promotes proliferation while regu-
lating lineage-specific differentiation (Lin et al., 2009; Smith
et al., 2010; Varlakhanova et al., 2010). However, Myc also
activates the Arf tumor suppressor encoded by Cdkn2a (also
called Ink4a-Arf), which in turn inhibits cell proliferation. In
somatic cells, this feedback mechanism prevents uncontrolled
cell proliferation, and its inactivation by mutations leads to
tumorigenesis (Cleveland and Sherr, 2004; Eischen et al.,
1999). Whereas cancer cells evade the Myc-Arf feedback
loop through mutations, how ESCs block this feedback to allow
rapid proliferation is unknown. Oct4, Sox2, and Nanog are
required for ESCs to maintain a low level of Arf messenger
RNA (mRNA) (Banito et al., 2009; Kawamura et al., 2009; Li
et al., 2009; Utikal et al., 2009). As these transcription factors
do not directly bind to Cdkn2a, it is unclear how the pluripo-
tency core antagonizes the Myc-Arf feedback loop to ensure
rapid ESC self-renewal.
Besides specific transcriptional regulation, two unique chro-
matin features contribute to the establishment and maintenance
of ESC pluripotency. A less compacted chromatin structure
compared to differentiated cells endows ESCs with highly
dynamic chromatin organization (Meshorer and Misteli, 2006).
Another chromatin feature of ESCs is the so-called poised
bivalent state of developmentally regulated genes that harbor
both transcriptionally active (histone 3-lysine 4 trimethylation,
H3K4me3) and transcriptionally repressive (histone 3-lysine
27 trimethylation, H3K27me3) epigenetic marks (Bernstein
et al., 2006), which are catalyzed by SET/MLL complexes and
PRC2, respectively (Ang et al., 2011; Boyer et al., 2006; Jiang
et al., 2011; Landeira et al., 2010; Li et al., 2010; Peng et al.,
2009; Shen et al., 2009; Pasini et al., 2010). These chromatin
features lead to a global transcriptional activity so that even
repressed developmentally regulated genes are expressed
sporadically (Efroni et al., 2008). Given that these mRNAs neither
accumulate to high levels nor translate into large amounts of
proteins in ESCs, active mechanisms must exist to prevent their
accumulation and translation. Understanding thesemechanisms
should shed light on these unique properties of ESCs.
The PRC2-catalyzed H3K27me3 is essential for maintaining
both the silenced and poised states of bivalent genes. PRC2
recognizes both CpG islands and chromatin features within
the GC-rich regions where most bivalent genes reside (Zhou
et al., 2011). However, because both CpG-island densities
and chromatin contexts of bivalent genes vary widely, addi-
tional regulatory mechanisms are likely required to ensure
that appropriate amounts of PRC2 are loaded onto individual
bivalent genes in ESCs so that they are neither overly nor insuf-
ficiently silenced. Indeed, recent studies of Jarid2, a component
of PRC2, have revealed complicated mechanisms of promoting
PRC2 loading and activities on bivalent genes. In addition to
promoting PRC2 loading, ESCs may actively limit PRC2 binding
via a presently unknown mechanism so that the bivalent genes
are not overly silenced. The function of PRC2 on bivalent genes
must also be coordinated with the core pluripotency factors. As
no physical interaction between the core factors and PRC2 has
been detected, the core factors may be coupled to PRC2
through their downstream effector(s) in ESCs.
The undifferentiated embryonic cell transcription factor 1 (Utf1)
is one of the direct downstream target genes of Oct4 and Sox2,
and it is highly expressed in mouse and human ESCs (Nishimoto
et al., 2005; Okuda et al., 1998; Tan et al., 2007). The highest
amount of Utf1 is found in the inner cell mass of mouse blasto-
cysts. After implantation, Utf1 expression is silenced in most
cells with the exception of some embryonic tissues (Okuda
et al., 1998). In ESCs, Utf1 is only found in the nucleus where it
tightly associates with chromatin, and during ESC differentiation,
Utf1 is rapidly downregulated. Although Utf1 has been impli-
cated in regulating ESC proliferation and differentiation, the
mechanism remains unclear (Nishimoto et al., 2005; van den
Boom et al., 2007). We report here that Utf1 is a component of
the bivalent chromatin that regulates gene expression in
a context-dependent manner, which connects the pluripotency
core to both Myc and PRC2 networks to ensure rapid prolifera-
tion and coordinated differentiation of ESCs.
RESULTS
Utf1 Binds to Bivalent Genes to Regulate Their
Expression
We expressed biotin-Utf1 at less than 5% of the endogenous
Utf1 level (Figure S1A available online), andwe used biotin-medi-
ated and crosslinked ChIP-sequencing (biotin-ChIP-seq) to mapUtf1-binding sites in ESCs (Kim et al., 2009, 2010; Shen et al.,
2009). We identified 75,029 chromatin regions with significant
Utf1 enrichments (false discovery rate [FDR] < 0.001). Utf1
binding was enriched in gene-rich regions with highest binding
near the transcription start sites (TSS) of genes containing
dense CpG islands (Figures 1A–1C and S1B). Gene ontology
(GO) analyses revealed a striking enrichment of Utf1 on genes
with functions in organ/system development and cell differentia-
tion (Figure S1C and Table S1).
PRC2-ChIP-seq using an antibody to Suz12 (a subunit of
PRC2) revealed that Utf1 binding strongly correlated with PRC2
binding (r = 0.71; Figures 1B–1D and S1B). Our Suz12-ChIP-
seq data set was consistent with previously published data
sets (r = 0.82) (Ku et al., 2008). Of the total 16,380 Utf1-bound
genes,6,116were bivalent genes (Table S2), and they exhibited
significantly stronger Utf1 enrichment within 5 kb up- and down-
stream of the TSS than those nonbivalent genes (Figure 1C).
Utf1 binding was highly correlated (r = 0.6) with H3K27me3
catalyzed by PRC2 but poorly correlated with H3K4me3 (r =
0.21) present on both bivalent promoters and promoters of
strongly expressed genes (Figures 1B, S1B, and S1D). Utf1
binding was not correlated with H3K9me3 (r = 0.17) found on
heterochromatin (Figure S1E). Using differentmotif-findmethods
(Bailey and Elkan, 1994; Zheng et al., 2011), we predicted two
similar AG-rich motifs recognized by Utf1 within CpG islands
(Figure 1E) closely resembling one of the two motifs previously
predicted to bind to Jarid2 in PRC2 (Peng et al., 2009). Thus,
Utf1 is preferentially enriched at the promoters of bivalent genes.
To study how Utf1 regulates gene expression, we generated
Utf1 null (Utf1/D) ESCs by gene targeting (Figures S1F and
S1G). Compared to control Utf1+/f ESCs, the Utf1/D ESCs ex-
pressed similar amounts of pluripotency proteins andSuz12 (Fig-
ure S1H) and maintained similar levels of euploidy under stan-
dard ESC culture conditions (Figure S1I). Using RNA-seq, we
found that 792 genes exhibited changes of expression by at least
1.5-fold (p < 105) in Utf1/D ESCs compared to Utf1+/f ESCs.
Importantly, Utf1 directly bound to 86.6% of the down- and
90.3% of the upregulated genes (Figures 1F and 1G; Tables S3
andS4). Themajority of these are bivalent genes. ThusUtf1 could
regulate either repression or activation of bivalent genes in ESCs.
Utf1 Limits Bivalent Gene Silencing by Preventing
Excessive PRC2 Binding and H3K27me3
Because Utf1 is strongly enriched on bivalent genes (Figures 1B
and 1C), we focused our study on the bivalent genes. We first
studied whether Utf1 could limit gene silencing by preventing
excessive PRC2 binding and H3K27me3 on bivalent genes
because Utf1 and PRC2 were predicted to bind to similar DNA
sequences (Figure 1E). ChIP-seq showed that Utf1/D ESCs
had up to 4-fold increase in PRC2 binding to bivalent genes
compared to Utf1+/f ESCs, which corresponded to a significant
increase in H3K27me3 on these genes (Figures 2A–2D and
S2A). Further ChIP analyses of histone H3 and H3K4me3
demonstrated that increased PRC2 binding and H3K27me3 on
bivalent genes were not due to some general change of chro-
matin upon Utf1 deletion (Figures 2E, 2F, S2B, and S2C).
We then used four means to show that Utf1 and PRC2 indeed
competitively bound to the same bivalent genes. First, we usedCell 151, 576–589, October 26, 2012 ª2012 Elsevier Inc. 577
Figure 1. Utf1 Binds Bivalent Genes to Regulate Their Expression
(A) Utf1 binding at bivalent promoters in ESCs. Biotin-ChIP-seq of BirA-expressing ESCs showed no significant binding of background biotinylated proteins to
chromatin (data not shown). Arrows, the start and direction of transcription. y axes, reads per kilobases per million reads (RPKM).
(B) Heatmap of annotated mouse-gene promoters enriched for Utf1, CpG, Suz12, H3K27me3 (Mikkelsen et al., 2007), and H3K4me3 in ESCs. ChIP-seq
enrichment (identified in this study) for Utf1, Suz12, and H3K4me3was calculated as the ratio of normalized tag counts of the ChIP-seq and the input sequence in
a 1 kb window that slides every 200 bp along 10 kb promoter regions. The heatmap is rank-ordered based on the enrichment of Utf1 (blue, enriched; white, not
enriched).
(C) Utf1 tag density on bivalent genes is higher than on the nonbivalent genes. The normalized Utf1-tag densities, determined as the averaged ratio of normalized
tag counts of Utf1-ChIP-seq and the input sample in the 200 bp window, are plotted within the 5 kb up- and downstream of TSS.
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RNA interference (RNAi) to reduce the PRC2 subunit Jarid2 (Fig-
ure S2D) and performed biotin-Utf1-ChIP-qPCR on selected
bivalent genes. This resulted in an increased binding of Utf1 to
the bivalent genes (graph in Figure S2D). Second, we re-
expressed Utf1 in Utf1/D ESCs (Figure S2E) and carried out
Suz12-ChIP-qPCR on selected bivalent genes. After re-express-
ing Utf1, the increase of Suz12 binding to the bivalent genes in
Utf1/D ESCs was reduced to levels similar to those seen in
Utf1+/f ESCs (graph in Figure S2E). Third, we performed electro-
phoretic mobility shift assay (EMSA) to show that Utf1 and PRC2
competitively bound to the DNA oligo containing the predicted
bindingmotifs for Utf1 and PRC2 (Figure S2F). Finally, sequential
ChIP-qPCR analyses on selected bivalent genes showed that
Utf1 and PRC2 co-occupied the same bivalent genes in wild-
type ESCs (Figure S2G). Thus, Utf1 prevents oversilencing of
bivalent genes by limiting PRC2 binding.
Utf1 Recruits the mRNA-Decapping Protein Dcp1a
to Bivalent Genes
To understand how Utf1 could also repress gene expression,
we used mass spectrometry (MS) to identify Utf1-interacting
proteins. Among the proteins identified by two rounds of MS
with a high peptide coverage (Table S5), we did not find either
ATF2 or any subunit of TFIID that was shown to interact with
Utf1 in somatic cells (Fukushima et al., 1998; Okuda et al., 1998).
However, we identified components of the mRNA-decapping
complex, Dcp1a, Ddx6, and Edc3, as candidate Utf1-interacting
proteins in ESCs (Ling et al., 2011; Tritschler et al., 2009).
By pulling down biotin-Utf1 expressed in ESCs, we showed
that whereas Dcp1a, Ddx6, and Edc3 coimmunoprecipitated
with Utf1, the RNA polymerase II (Pol II) and Taf1, two abundant
nuclear proteins, were not detectable in the immunoprecipitate
(Figure 3A). Consistent with the absence of the catalytic subunit
Dcp2 (cleaves the 50-methyl cap of mRNAs) in the MS analyses
(Table S5), Dcp2 was not detected in Utf1 immunoprecipitates
(Figure 3A). We found that Dcp1a, Ddx6, and Edc3 were present
in ESC nuclear extracts, whereas Dcp2 was only found in the
whole-cell lysate (Figure 3B). Similarly, immunofluorescence
staining revealed that whereas Dcp1a, Ddx6, and Edc3 were
present in both the nucleus and the cytoplasm, Dcp2 was only
found in the cytoplasm of ESCs (Figure 3C). Thus Utf1 binds to
three noncatalytic subunits of the mRNA-decapping complex
in the ESC nucleus.
A clear reduction of bright Dcp1a+ granules in both the nucleus
and the cytoplasmwas seen in ESCs upon Utf1 loss and was not
due to the reduction of the decapping proteins (Figures 3D–3F).
Instead, as formation of mRNP-processing granules requires
efficient loading of proteins like Dcp1a onto mRNAs, the re-
duction of Dcp1a+ granules in Utf1/D ESCs suggests that Utf1
facilitates the recruitment of the noncatalytic subunits of the
mRNA-decapping complex to bivalent promoters so they can
be loaded onto newly transcribedmRNAs in the nucleus. Indeed,(D) Scatterplot of the correlation between Utf1 and Suz12 binding on promoters
calculate the tag enrichment. Spearman’s rank correlation coefficient, r = 0.71.
(E) Two AG-rich sequence motifs that are enriched in Utf1-bound loci are highly
(F and G) Down- (F) or upregulated (G) genes in Utf1/D ESCs compared to Utf1
See also Figure S1 and Tables S1, S2, S3, and S4.sequential ChIP-qPCR of randomly selected bivalent genes
showed that Dcp1a and Utf1 co-occupied these genes (Fig-
ure 3G). Importantly, the binding of Dcp1a to bivalent genes
decreased significantly uponUtf1 loss, whichwas rescued by re-
introducing Utf1 into these ESCs (Figure 3H). Given that the
reduction of Dcp1a binding in the absence of Utf1 is incomplete,
additional factors may mediate Dcp1a recruiting.
Utf1 Promotes the Binding of Dcp1a to mRNA
in the Nucleus for Cytoplasmic Degradation
RNA-seq showed that reduction of Dcp1a by two different
short hairpin RNAs (shRNAs) in ESCs resulted in upregulation
of many Utf1-bound bivalent genes, including Arf and Hoxa1,
without affecting the expression of Nanog, Oct4, Sox2, Utf1,
and Suz12 (Figure 4A and Table S6). To show that Utf1 tags
the mRNA from leaky bivalent promoters for cytoplasmic degra-
dation by recruiting Dcp1a, we focused on the bivalent gene
Arf because it exhibited a low level of expression in Utf1+/f
ESCs, which was further upregulated in Utf1/D ESCs (Figures
S3A–S3D). The low level of Arf expression in wild-type
ESCs could be due to the binding of the transcriptional activator
Myc (Figure S3A). Consistent with the idea that Utf1 represses
Arf expression posttranscriptionally, both the nuclear run-on
assay and the transcriptional elongation assay showed that
Utf1 did not inhibit Arf transcription (Figures 4B and 4C). Treat-
ing ESCs with the Myc inhibitor 10058-F4 (Rahl et al., 2010)
caused a similar reduction of Arf transcription in both Utf1+/f
and Utf1/D ESCs (Figure 4B), which was consistent with
a role of Myc in activating Arf transcription in ESCs. Finally, S1
nuclease protection assays showed that Arf mRNA was prop-
erly spliced in the nucleus of Utf1+/f ESCs (Figure S3E). Thus,
Utf1 does not regulate Arf transcription or splicing in the
nucleus.
We then performed RNA immunoprecipitation (RIP) with
Dcp1a antibody and nuclear extracts made from Utf1/D and
Utf1+/f ESCs. qPCR analyses showed that the binding of
Dcp1a to Arf mRNA was significantly reduced upon Utf1
loss (Figure 4D). Next, we used flavopiridol to inhibit Pol II
(Rahl et al., 2010) and northern blotting to probe for Arf mRNA
levels. We found that Utf1/D ESCs were less efficient in degrad-
ing Arf mRNA compared to Utf1+/f ESCs (Figure 4E). Thus, Utf1
recruits Dcp1a to bivalent promoters, which facilitates the
loading of Dcp1a to mRNAs transcribed from leaky bivalent
genes for cytoplasmic degradation.
Utf1 Buffers Bivalent Gene Expression in
a Context-Dependent Manner
The above findings reveal that whereas Utf1 limits PRC2 binding
to prevent excessive H3K27me3 and bivalent gene silencing, it
also recruits Dcp1a to bivalent genes to repress gene expression
through mRNA pruning (Figure 5A). These dual functions could
allow Utf1 to enforce the poised state of bivalent genes residing. A window of 1 kb up- and downstream of the TSS of all genes was used to
similar to the predicted Jarid2-bound AG-rich motif.
+/f ESCs as shown by RNA-Seq.
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Figure 2. Utf1 Binds to Bivalent Genes to Limit PRC2 Loading and H3K27me3
(A) Plots of ChIP-seq peaks at ten genomic loci. y axes, RPKM of ChIP-seq of Utf1, Suz12, and H3K27me3. The increase (red peaks) or decrease (blue peaks
below zero, hardly visible due to very little decrease) of Suz12 binding and H3K27me3 in response to Utf1 depletion are plotted as log2 fold changes on y axes.
Genomic regions that are further analyzed by ChIP-qPCR (see E and F below) are shaded gray.
(B) Heatmap of all bivalent genes identified in this study showing the enrichment of CpG, Utf1, H3K4me3, H3K27me3 (in Utf1+/f or Utf1/D ESCs), and Suz12 (in
Utf1+/f or Utf1/D ESCs) and the relative increase of Suz12 binding or H3K27me3 upon Utf1 depletion. The heatmap is rank-ordered based on the enrichment of
Suz12 in control ESCs. The increase in Suz12 binding and H3K27me3 was calculated by the log-ratio of normalized Suz12 and H3K27me3 tag density between
Utf1/D and Utf1+/f ESCs.
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Figure 3. Utf1 Recruits the Noncatalytic
Subunit of the mRNA-Decapping Complex
to Bivalent Genes
(A) Biotin-Utf1 coprecipitates with Dcp1a, Ddx6,
and Edc3, but not Dcp2, Taf1, and Pol II in wild-
type ESCs. Streptavidin pulled-down (Str-P) of
biotin-Utf1 was probed for the indicated anti-
bodies by western blotting analyses.
(B) Western blotting analyses of nuclear extracts
and whole-cell lysates of wild-type ESCs. Tubulin,
cytoplasmic protein control.
(C) Immunolocalization of Dcp1a, Ddx6, Edc3, and
Dcp2 in wild-type ESCs. Areas in white dashed
squares are enlarged at the bottom of each
image. Arrows, proteins in the region occupied by
chromatin stained by Hoechst (blue) or in the
cytoplasm. Scale bar, 10 mm.
(D) A reduction of Dcp1a+ granule numbers and
intensity in Utf1/D ESCs compared to Utf1+/f
ESCs. Areas in dashed squares are enlarged to the
right of each image. Arrows, Dcp1a+ granules in
the Hoechst-stained chromatin region. Scale bar,
10 mm.
(E) Quantifications of Dcp1a+ granules in Utf1/D
and Utf1+/f ESCs.
(F) Utf1/D and Utf1+/f ESCs express similar
amounts of Dcp1a, Ddx6, and Edc3. Loading
controls, tubulin.
(G) Dcp1a-ChIP samples were re-ChIPed using
streptavidin beads followed by qPCR of bivalent
genes in Utf1+/f ESCs expressing BirA alone or
BirA plus biotin-Utf1.
(H) ChIP-qPCR of Dcp1a binding at bivalent genes
in Utf1+/f or Utf1/D ESCs transfected with control
vector pCAG or pCAG-Utf1. Restoration of Utf1
expression (see Figure S2E for Utf1 western)
rescued Dcp1a binding in Utf1/D ESCs. The IgG
antibody was used as controls.
Error bars, SD of triplicates. Student’s t test,
**p < 0.01. See also Table S5.in different DNA and chromatin contexts. We analyzed whether
the downregulated bivalent genes upon Utf1 loss have different
chromatin and DNA contents compared to the upregulated
genes. We found that the upregulated genes have lower CpG(C and D) MA-plots of Suz12 binding (C) and H3K27me3 (D) on all promoters inUtf1/D and Utf1+/f ESCs. Two
is shown here. Log2 of the normalized Suz12 or H3K27me3 tag densities within 1 kb to 1 kb up- and downs
averaged and plotted on the x axes. The y axes are the log-ratio of Suz12 or H3K27me3 tag densities betw
(E and F) ChIP-qPCR of Suz12 binding (E) and H3K27me3 (F) at selected genes in Utf1+/f and Utf1/D ESCs
standard deviations (SD) of triplicates. Student’s t test, *p < 0.05, **p < 0.01.
See also Figure S2 and Table S2.
Cell 151, 576–589,island densities and weaker PRC2
binding than the downregulated genes
(Figures 5B–5D). Importantly the upregu-
lated genes exhibited less PRC2 binding
increase upon Utf1 loss than the downre-
gulated genes (Figures 5B, 5E, and 5F).
These analyses suggest the following
modes of context-dependent bivalent
gene regulation by Utf1. For bivalentgenes that have low CpG island densities and PRC2 binding
or are bound by strong transcriptional activators (see Arf as
an example), Utf1 would repress gene expression because
the loss of mRNA pruning due to Utf1 loss could not bebiological repeats give similar results. One data set
tream of the TSS in Utf1+/f and Utf1/D ESCs were
een Utf1/D and Utf1+/f ESCs.
. The Actb locus was used as controls. Error bars,
October 26, 2012 ª2012 Elsevier Inc. 581
Figure 4. Utf1 Promotes the Binding of
Dcp1a to mRNAs in the Nucleus for Cyto-
plasmic Degradation
(A) Western blotting analyses of Utf1+/f ESCs
treated with control or Dcp1a shRNAs. Loading
controls, tubulin. The graph shows RT-qPCR of
mRNA levels of indicated genes in the control,
Dcp1a-shRNA-treated Utf1+/f ESCs, or untreated
Utf1/D ESCs.
(B) 32P-labeled transcripts from Myc inhibitor-
treated (9 hr) and untreated (0 hr) ESCs were
hybridized to nitrocellulose filters spotted with Arf
or Txnip cDNAs (two spots per gene). Txnip is
a nonbivalent gene not regulated by Myc (Rahl
et al., 2010). The graph shows quantifications of
the nuclear run-on assays. The Arf hybridization
intensity was normalized to the Txnip intensity and
plotted.
(C) The elongation rate of Pol II at the Arf locus in
Utf1+/f and Utf1/D ESCs measured by the ratio of
ChIP-qPCR of Pol II at exon 2 and at the promoter
region of Arf.
(D) RIP using Dcp1a antibody inUtf1+/f andUtf1/D
ESCs followed by RT-qPCR analyses.
(E) Arf mRNA decay was determined by northern
blotting in Utf1+/f and Utf1/D ESCs after tran-
scriptional arrest by flavopiridol. Loading control,
18S rRNA. The Arf mRNA band intensity normal-
ized to the 18S RNA band intensity at time 0 was
defined as 100%. The normalized Arf band inten-
sities at other time points were calculated relative
to the time 0.
Error bars, SD. Student t test, *p < 0.05, **p < 0.01.
See also Figure S3 and Table S6.compensated for by the limited gaining of PRC2 (Figure 5G).
By contrast, for bivalent genes with high CpG island densities
and strong PRC2 binding, Utf1 would prevent gene silenc-
ing because upon Utf1 deletion, the loss of mRNA pruning
would be overcompensated by the excessive gaining of PRC2
(Figure 5H).
We have shown that Utf1 uses Dcp1a to repress genes such
as Hoxa1 and Arf (Figure 4A; Tables S4 and S6), which is consis-
tent with the model in Figure 5G. Because our studies suggest
that Utf1 recruits Dcp1a to bivalent genes, we analyzed how
the loss of Dcp1a could affect the expression of genes that
use Utf1 to limit their repression (see Figure 5H). As these genes
exhibit stronger PRC2 binding than the other bivalent genes,
Dcp1a loss may or may not affect their expression depending
on the strength of PRC2-mediated gene repression. Indeed,
we found that 56% (164/295) of them did not show gene expres-
sion change upon Dcp1a loss, suggesting that PRC2 was suffi-
cient for their repression. We did find that 41% (121 out of 295)
of bivalent genes in this group underwent upregulation upon
Dcp1a reduction, suggesting that they depended on both582 Cell 151, 576–589, October 26, 2012 ª2012 Elsevier Inc.PRC2 and Dcp1a for repression. The
above analyses predict that whereas
Utf1 functions in ESCs to maintain
rapid cell proliferation by repressing Arf
expression through Dcp1a-mediatedmRNA pruning, both the mRNA pruning and the epigenetic func-
tions of Utf1 also ensure proper gene expression during ESC
differentiation.
Utf1 Antagonizes Myc-Mediated Activation of Arf
to Ensure Rapid Proliferation of ESCs
We found that Arf protein levels in Utf1/D ESCs were reduced
either by reintroducing Utf1 or by inhibiting c-Myc (Figures S4A
and S4B), demonstrating that Utf1 functions downstream of
Oct4 and Sox2 to antagonize the Myc-Arf feedback loop.
Although both Utf1+/f and Utf1/D ESCs expressed similar
amounts of pluripotency proteins (Figures S1H and S4C), the
Utf1/D ESCs had higher amounts of Arf in the nucleus, flatter
colony morphologies, and slower proliferation rates compared
to Utf1+/f ESCs (Figures 6A–6C). Consistently, teratomas formed
by Utf1/D ESCs were much smaller than those of Utf1+/f ESCs
(Figure S4D). Inhibiting Arf expression using shRNA (Figure 6D)
resulted in a significant increase of cell proliferation rates in
Utf1/D ESCs without affecting the rate of Utf1+/f ESCs (Fig-
ure 6C). Thus upregulation of Arf upon Utf1 deletion was
Figure 5. Utf1 Regulates Bivalent Genes in a Context-Dependent Manner
(A) Illustration of the dual functions of Utf1 on bivalent genes.
(B) TheHeatmap of gene expression inUtf1+/f andUtf1/DESCs (red and green, high and low expression, respectively). The profiles of Utf1 binding, Suz12 binding
(inUtf1+/f orUtf1/D ESCs), Suz12-binding increase (inUtf1/D ESCs), and CpG densities of these genes are also shown as heatmaps that are rank-ordered based
on Suz12-binding strength in Utf1+/f ESCs. The gene expression heatmap shows that Utf1 buffers gene expression.
(C) Quantifications of CpG densities at the TSS of Utf1-activated (downregulated upon Utf1 loss, red) and Utf1-repressed (upregulated upon Utf1 loss, black)
genes. The CpG density is determined by the percentage of CpG dinucleotides in 200 bp windows and plotted within 2 kb up- and downstream of the TSS
(Wilcoxon two-sample test, ***p < 0.001).
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responsible for the slow ESC proliferation. Reduction of Arf in the
Utf1/D ESCs also partially reversed the flattened colony
morphology (Figure 6E). The incomplete reversal of the prolifer-
ation rate and colony morphology of Arf-RNAi-treated Utf1/D
ESCs is consistent with our finding that Arf is only one of the
targets of Utf1 in ESCs.
The p53-p21Cip1 pathway represents the best characterized
mechanism by which Arf inhibits cell-cycle progression (Pomer-
antz et al., 1998; Zindy et al., 1998). The binding of Arf to Mdm2,
an ubiquitin ligase for p53, leads to Mdm2 inhibition and p53
accumulation. The increase in p53 could lead to transcriptional
upregulation of the cell-cycle inhibitor p21Cip1, which would
slow down cell-cycle progression. We found that although Arf
upregulation led to a small increase of p53 levels in Utf1/D
ESCs, p21Cip1 was not upregulated (Figures 6A and 6F). Simi-
larly, although transient overexpression of Arf in Utf1+/f ESCs
strongly increased p53 protein levels and inhibited cell-cycle
progression, p21Cip1 expression was unchanged (Figures 6G,
6H, and S4E–S4G). Thus, Utf1 functions downstream of Oct4
and Sox2 to ensure rapid cell-cycle progression by blocking
the Myc-Arf feedback loop independent of p53-p21Cip1 in ESCs.
Utf1 Coordinates Gene Expression during ESC
Differentiation
We next studied whether Utf1 is required for proper bivalent
gene expression during ESC differentiation by investigating their
expression in either ectoderm (such asOlig2 andNestin) or mes-
oendoderm (such as T andHoxa1).Olig2,Nestin, and T exhibited
a significant increase in PRC2 binding and H3K27me3 upon Utf1
loss (see Figures 2A, 2E, and 2F). Hoxa1 was upregulated either
upon Utf1 loss or uponDcp1 RNAi (see Figure 4A; Tables S4 and
S6), suggesting that the mRNA-pruning mechanism is important
for controlling Hoxa1 expression. We used embryoid body (EB)-
based differentiation and qPCR assays and found that whereas
Olig2, Nestin, and T were insufficiently upregulated, Hoxa1
underwent excessive upregulation during EB differentiation
of Utf1/D ESCs compared to Utf1+/f ESCs (Figure 7A). Addi-
tional qPCR analyses of other bivalent genes expressed in
mesoendoderm (Gata6 and Bmp4) or during epithelium-to-
mesenchyme transition (EMT, Cd44) revealed a similar misregu-
lation (Figure 7A).
To study how Utf1 could affect gene expression and lineage-
specific differentiation, we used ZHBTc4 ESCs, in which the
endogenous Oct4 was replaced by a tetracyclin (Tc)-regulated
Oct4 transgene (Niwa et al., 2000). ZHBTc4 ESCs undergo effi-
cient trophectoderm (TE) differentiation in the presence of Tc.
The upregulation of the transcription factor Cdx2 during TE
development in vivo is required for establishing progenitor cells
for TE (Niwa et al., 2005). In vitro, Cdx2 is not essential for(D) Quantifications of Suz12 binding at the TSS of Utf1-activated (downregulated u
within 5 kb up- and downstream of the TSS (Wilcoxon two-sample test, ***p < 0
(E) Quantifications of Suz12-binding increase upon Utf1 loss at the TSS of Utf1-ac
Utf1 loss) genes within 5 kb up- and downstream of the TSS (Wilcoxon two-sam
(F) Suz12-ChIP-qPCR of Utf1-repressed (upregulated upon Utf1 loss, top plot) an
RNA-Seq. Error bars, SD of triplicates. Student’s t test, *p < 0.05, **p < 0.01.
(G and H) Illustrations for the context-dependent buffering of bivalent genes by Ut
(by limiting PRC2 binding) genes are indicated. Upon Utf1 loss, bivalent genes ma
PRC2-binding increase, Dcp1a loss, and other transcription activators (such as
584 Cell 151, 576–589, October 26, 2012 ª2012 Elsevier Inc.terminal TE differentiation from ESCs, but it is required for the
establishment and maintenance of trophoblast stem (TS) cells
that undergo further terminal differentiation into TE lineages
(Niwa et al., 2005). Upon Utf1 loss, the Cdx2 gene locus ex-
hibited a significant increase of PRC2 binding and H3K27me3
in ESCs (see Figures 2E and 2F), predicting that Cdx2 would
not be sufficiently upregulated when Utf1-knockdown ESCs
were induced to differentiate toward TE. Consistently, we found
that addition of Tc to ZHBTc4 ESCs treated with Utf1 shRNA led
to insufficient Cdx2 upregulation (Figure 7B) and rapid terminal
differentiation as judged by the formation of large and flat
terminally differentiated TE cells, whereas the control shRNA-
treated ZHBTc4 ESCs formed many colonies made of small
TS-like cells upon Tc and FGF4 treatment (Figures 7C and 7D).
Thus although Utf1 deletion did not block the differentiation of
ESCs to TE, it disrupted proper coupling between proliferation
and differentiation.
DISCUSSION
Using a combination of genomic, cell biology, proteomic, and
gene-targeting approaches, we uncover a mechanism that
integrates the pluripotency core factors with the PRC2-based
epigenetic network and Myc regulation. This mechanism has
three features. First, the core factors use their direct downstream
target Utf1, which itself is a chromatin-associated protein
enriched at bivalent genes, to control both self-renewal and
proper differentiation. Second, the core factors use Utf1 to block
the Myc-Arf feedback loop to ensure rapid cell proliferation. An
important function of the core factors in reprogramming is to
block the expression of Arf and Ink4a. However, because none
of the core factors directly binds to Cdkn2a, the mechanism of
repression has remained unknown. Our findings provide the
critical missing molecular link that allows ESCs to evade the
Myc-Arf feedback control. Third, Utf1 integrates all three
networks using both epigenetic regulation and a previously
unappreciated mRNA pruning mechanism (Figure 7E).
The differential PRC2 loading on bivalent genes invites the
question of how the genes with high or low PRC2 binding are
neither oversilenced nor derepressed, respectively. We show
that Utf1 and PRC2 bind to bivalent genes competitively
because they recognize similar AG-rich motifs, which allows
Utf1 to prevent excessive loading of PRC2 in ESCs. How Utf1
or PRC2 binds to chromatin is unclear. Interestingly, H2AZ is
one of the Utf1-interacting proteins identified in ourMS analyses.
Because H2AZ binds to PRC2-bound genes (Creyghton et al.,
2008), studying the functional relationship between H2AZ and
Utf1 may help to understand how Utf1 is loaded onto bivalent
genes. We note that our biotin-Utf1-ChIP-seq data are notpon Utf1 loss) and Utf1-repressed (upregulated upon Utf1 loss) bivalent genes
.001).
tivated (downregulated upon Utf1 loss) and Utf1-repressed (upregulated upon
ple test, ***p < 0.001).
d Utf1-activated (downregulated upon Utf1 loss, bottom plot) genes found by
f1. The dual functions of Utf1 in repressing (by recruiting Dcp1a) and activating
y undergo upregulation (G) or downregulation (H), depending on the degree of
Myc in the Arf locus) on these genes.
Figure 6. Utf1 Promotes Proliferation of ESCs through Inhibiting Arf Expression
(A) Representative immunofluorescence images of Arf and p53 proteins in Utf1+/f and Utf1/D ESCs. Scale bar, 10 mm.
(B) Utf1/D ESCs appear flatter than Utf1+/f ESCs. Both types of ESCs are positive for the pluripotency marker alkaline phosphatase (AP). Arrows indicate
spontaneous differentiation at the edges of Utf1/D ESC colonies.
(C)Utf1/D ESCs proliferated slower thanUtf1+/f ESCs. Reduction ofArf by shRNA significantly enhancedUtf1/D ESC proliferation without affectingUtf1+/f ESCs.
The top graph plots cell numbers. The bottom graph plots the percentages of Utf1/D ESCs normalized against Utf1+/f ESCs. Error bars, SD of triplicates.
(D) shRNA reduction of Arf expression in both Utf1+/f and Utf1/D ESCs. Loading controls, tubulin.
(E) Inhibiting Arf expression reverted the flattened ESC colonies back to the morphology similar to the Utf1+/f ESCs.
(F) Western blotting analyses of Ink4a, p53, Arf, and p21Cip1 in Utf1+/f and Utf1/D ESCs. Controls, wild-type MEFs. Loading controls, tubulin.
(G) Western blotting analyses of Arf overexpression 16 hr post-transfection of ESCs, which had increased p53 but not p21Cip1. Controls, wild-typeMEFs. Loading
controls, tubulin.
(H) Overexpression of Arf in Utf1+/f ESCs resulted in a significant reduction of cell proliferation 16 hr post-transfection.
Error bars, SD of triplicates. Student’s t test in (C) and (H), *p < 0.05, **p < 0.01. See also Figure S4.
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Figure 7. Utf1 Regulates Proper Differentia-
tion by Coordinating Gene Expression in
ESCs
(A) Time-course RT-qPCR analyses of develop-
mental regulators normalized toGAPDH during EB
differentiation in Utf1+/f and Utf1/D ESCs. Error
bars, SD of triplicates.
(B) Western blotting analyses showed that Utf1
shRNA reduced Utf1 protein levels in ZHBTc4
ESCs compared to control GFP shRNA. Time-
course RT-qPCR analyses of Cdx2 mRNA during
TE differentiation was normalized to GAPDH and
plotted. Error bars, SD of triplicates.
(C) Images of TS cells or terminally differentiated
TE cells derived from GFP-shRNA- or Utf1-
shRNA-treated ZHBTc4 ESCs, respectively.
(D) Quantifications of TS colonies in GFP-shRNA-
and Utf1-shRNA-treated cells 6 days after differ-
entiation. Error bars, SD of triplicates. Student’s
t test in (A), (B), and (D), *p < 0.05, **p < 0.01.
(E) A model. Utf1 couples three regulatory net-
works to ensure proper proliferation and differen-
tiation of ESCs.consistent with the native-ChIP-on-chip studies of Utf1 (Kooistra
et al., 2010). The native-ChIP procedure involved micrococcal
nuclease treatments and additional manipulations for extended
time without cross-linking, which could fail to capture the true
Utf1-chromatin interactions.
Our data suggest that by binding to Dcp1a, Ddx6, and Edc3,
Utf1 ensures that mRNAs transcribed from leaky bivalent genes
are tagged for efficient degradation by the mRNA-decapping
pathway. The mRNA-decapping complex, which has only been
studied in fungi and in animal somatic cells, promotes the forma-
tion of mRNP-processing granules that either prevent mRNA
translation or facilitate mRNA degradation (Ling et al., 2011;
Tritschler et al., 2009). Our findings have revealed a previously
unappreciated function of the mRNA-decapping complex in
silencing bivalent genes that are insufficiently repressed in
ESCs. As a component of the mRNA-decapping complex,
Dcp1a could promote both the binding of mRNA to Dcp2 and
the decapping activity of Dcp2 to facilitate mRNA degradation
in the ESC cytoplasm. Dcp1a could also promote mRNA turn-586 Cell 151, 576–589, October 26, 2012 ª2012 Elsevier Inc.over through microRNAs in ESCs (Ling
et al., 2011; Tritschler et al., 2009).
The promoter-mediated mRNA-
pruning function defined here may repre-
sent an important mechanism to ensure
ESC maintenance. Interestingly, two re-
cent studies in yeast have shown that
promoters can dictate mRNA stability by
recruiting proteins that target mRNAs
for cytoplasmic degradation (Bregman
et al., 2011; Trcek et al., 2011). Although
the proteins involved in the promoter-
based marking of mRNAs are different
in the yeast studies and in our study,
our findings strongly suggest that thepromoter-mediated control of mRNA stability is evolutionarily
conserved.
Dcp1a, Edc3, and Dcp2 have been found in the same complex
with TTF2 (a transcriptional terminator), and they have been
implicated in facilitating mRNA decapping during transcription,
which inhibits transcriptional elongation in both HeLa and
HEK293 cells (Brannan et al., 2012). Dcp1a has also been shown
to bind to Smad4 to activate target genes upon TGF-b signaling
in different somatic tissue culture cells (Bai et al., 2002).
However, unlike these previous reports, our studies show that
the Utf1-mediated recruiting of Dcp1a to bivalent promoters in
ESCs does not affect transcription, but it tags mRNA for post-
transcriptional degradation in the cytoplasm.
The buffer function of Utf1 that we uncovered suggests that
although removing Utf1 may not block lineage specification
and differentiation, it would lead to inappropriate coupling of
developmental processes and cell proliferation. Our preliminary
analyses of Utf1 null mice are consistent with this prediction
(data not shown). Utf1 is localized on the human chromosome
10q26.3, near the telomere. Humans bearing a heterozygous
deletion of 10q26.3 exhibit a number of developmental
abnormalities and retarded growth (Kehrer-Sawatzki et al.,
2005). Our findings suggest that Utf1 heterozygosity could be
responsible for some of the abnormalities in the 10q26.3
patients.
EXPERIMENTAL PROCEDURES
Karyotype Analyses of ESCs and Differentiation Assays
These procedures were performed as described previously (Creyghton et al.,
2008; Kim et al., 2011; Niwa et al., 2000; Vong et al., 2010) and in the Extended
Experimental Procedures.
Utf1 Pull-Down, Western Blotting, and MS
V6.5 ESCs (1–23 109) were used to make nuclear extracts. After dialyzing the
extract into a low-salt buffer, a Utf1 polyclonal antibody was used to immuno-
precipitate Utf1 and its associated proteins. ESCs (1 3 107) expressing either
BirA alone or both BirA and biotin-Utf1 were used for streptavidin pull-down of
biotin-Utf1. See the Extended Experimental Procedures for more details.
Cell Proliferation Assay
To perform long-term proliferation assays, 105 Utf1+/f or Utf1/D ESCs
were seeded into a single well of a 6-well plate. The cells in each well were
counted and replated every 2 days. The Utf1+/f ESCs were diluted so that
105 cells were plated in a fresh well. The same dilution factor was used to dilute
the Utf1/D ESCs into a new well. As Utf1/D ESCs grew slower, fewer Utf1/D
ESCs than Utf1+/f ESCs were plated each time. The cumulative total cell
number was calculated at each time point and used to plot the growth curve.
The cell number ratios of control-treated Utf1+/f ESCs to other experimental
groups of ESCs at each time point were used to plot the normalized growth
curve.
RNAi-Mediated Gene Silencing in ESCs
shRNAs were purchased from Open Biosystems to knock down the mRNA of
Arf (TRCN0000077816), Utf1 (TRCN0000081708), Jarid2 (TRCN0000096642),
and Dcp1a (shRNA-1:TRCN0000096664, shRNA-2:TRCN0000096665). See
the Extended Experimental Procedures for more details.
ChIP Assays
The ChIP-qPCR and ChIP-seq assays were performed according to the con-
ditions suggested by the manufacturers of ChIP-grade antibodies to
H3K27me3 (Abcam, ab6002), H3K4me3 (Cell Signaling, 9751), Suz12 (Cell
Signaling, 3737), and Dcp1a (WH0055802) with modifications (Jia et al.,
2007). Biotin-ChIP was performed as previously described (Kim et al., 2009).
See the Extended Experimental Procedures for detailed procedures, data
analyses, and primer information.
Sequential ChIP Assay
Sample treatment and immunoprecipitations were performed using standard
ChIP assay procedures. After the first immunoprecipitation, chromatin was
eluted in a solution of 30 mM DTT, 500 mM NaCl, and 0.1% SDS at 37C as
described (Bernstein et al., 2006). Eluted chromatin was diluted 50-fold and
subjected to biotin-Utf1-ChIP as described in the Extended Experimental
Procedures.
Whole-Transcriptome Shotgun Sequencing (RNA-Seq)
Total RNA was isolated from 107 ESCs with the RNeasy Plus kit (QIAGEN). The
poly(A)-containing mRNAs were purified, and libraries were built following
Illumina TruSeq RNA protocols. Libraries were sequenced using an Illumina
HiSeq 2000. 100 bp-long reads from both ends were obtained. See the
Extended Experimental Procedures for more details.
Cell-Cycle Analyses
ESCs were trypsinized and resuspended in 0.5 ml PBS followed by the addi-
tion of 0.5 ml of 100% ice-cold ethanol in a drop-wise manner while vortexing.After incubation for 20 min on ice, cells were harvested and washed by PBS
containing 1% FBS. Next, cells were incubated in PBS with 25 mg/ml RNase
A at 37C for 30 min to digest RNA. Finally, cells were stained by 50 mg/ml pro-
pidium iodide for 10 min at room temperature and analyzed by flow-cytometry
using BD-FACS Calibur.
Determining mRNA Degradation Profile
ESCs were cultured as described above. Cells were treated with 1 mM
flavopiridol (Sigma cat #F3055) and harvested at different time points.
mRNA extraction and northern blotting analyses are described in the Extended
Experimental Procedures.
Nuclear Run-on and S1 Nuclease Protection Assays
ESCs were cultured as described above. Cells were treated with 50 mM c-Myc
inhibitor 10058-F4 (Sigma cat #F3680) and harvested after 9 hr. Whole ESC
and nuclear extract were harvested as described above. S1 nuclease protec-
tion assay was performed as previously described (Mendrysa and Perry,
2000). For details, see the Extended Experimental Procedures.
EMSA
A 74 bp mouse genomic sequence containing the predicted Utf1- and Jarid2-
binding motifs was labeled by g-32P-ATP and incubated with ESC nuclear
extract. The unlabeled competitor probe was used at 100-fold excess to the
labeled probe. Super-shift was performed by incubating the reactions with
antibodies against Utf1 or Suz12. For details, see the Extended Experimental
Procedures.
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